205 related articles for article (PubMed ID: 34080970)
1. Recent Advancement of Pyrazole Scaffold Based Neuroprotective Agents: A Review.
Das S; Akbar S; Ahmed B; Dewangan RP; Iqubal MK; Iqubal A; Chawla P; Pottoo FH; Joseph A
CNS Neurol Disord Drug Targets; 2022; 21(10):940-951. PubMed ID: 34080970
[TBL] [Abstract][Full Text] [Related]
2. Recent Advancement in Drug Design and Discovery of Pyrazole Biomolecules as Cancer and Inflammation Therapeutics.
Alam MJ; Alam O; Naim MJ; Nawaz F; Manaithiya A; Imran M; Thabet HK; Alshehri S; Ghoneim MM; Alam P; Shakeel F
Molecules; 2022 Dec; 27(24):. PubMed ID: 36557840
[TBL] [Abstract][Full Text] [Related]
3. The therapeutic voyage of pyrazole and its analogs: A review.
Khan MF; Alam MM; Verma G; Akhtar W; Akhter M; Shaquiquzzaman M
Eur J Med Chem; 2016 Sep; 120():170-201. PubMed ID: 27191614
[TBL] [Abstract][Full Text] [Related]
4. Recent Advances in the Development of Pyrazole Derivatives as Anticancer Agents.
Zhang Y; Wu C; Zhang N; Fan R; Ye Y; Xu J
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628906
[TBL] [Abstract][Full Text] [Related]
5. Heterocycles in Breast Cancer Treatment: The Use of Pyrazole Derivatives.
Ardevines S; Marqués-López E; Herrera RP
Curr Med Chem; 2023; 30(10):1145-1174. PubMed ID: 36043746
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of Chromone-Related Pyrazole Compounds.
Santos CMM; Silva VLM; Silva AMS
Molecules; 2017 Oct; 22(10):. PubMed ID: 28981465
[TBL] [Abstract][Full Text] [Related]
7. Discovery of Anticancer Agents from 2-Pyrazoline-Based Compounds.
Li QS; Shen BN; Zhang Z; Luo S; Ruan BF
Curr Med Chem; 2021; 28(5):940-962. PubMed ID: 32141413
[TBL] [Abstract][Full Text] [Related]
8. Overview of recent developments of pyrazole derivatives as an anticancer agent in different cell line.
Bennani FE; Doudach L; Cherrah Y; Ramli Y; Karrouchi K; Ansar M; Faouzi MEA
Bioorg Chem; 2020 Apr; 97():103470. PubMed ID: 32120072
[TBL] [Abstract][Full Text] [Related]
9. Pyrazole; A Privileged Scaffold of Medicinal Chemistry: A Comprehensive Review.
Kumar R; Sharma R; Sharma DK
Curr Top Med Chem; 2023; 23(22):2097-2115. PubMed ID: 37455456
[TBL] [Abstract][Full Text] [Related]
10. Recent Progress in Anticancer Agents Incorporating Pyrazole Scaffold.
Mor S; Khatri M; Punia R; Sindhu S
Mini Rev Med Chem; 2022; 22(1):115-163. PubMed ID: 33823764
[TBL] [Abstract][Full Text] [Related]
11. The Synthetic and Biological Attributes of Pyrazole Derivatives: A Review.
Dwivedi J; Sharma S; Jain S; Singh A
Mini Rev Med Chem; 2018; 18(11):918-947. PubMed ID: 28971774
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Substituted Pyrazole-Based Kinase Inhibitors in One Decade (2011-2020): Current Status and Future Prospects.
El-Gamal MI; Zaraei SO; Madkour MM; Anbar HS
Molecules; 2022 Jan; 27(1):. PubMed ID: 35011562
[TBL] [Abstract][Full Text] [Related]
13. Recently reported biological activities of pyrazole compounds.
Faria JV; Vegi PF; Miguita AGC; Dos Santos MS; Boechat N; Bernardino AMR
Bioorg Med Chem; 2017 Nov; 25(21):5891-5903. PubMed ID: 28988624
[TBL] [Abstract][Full Text] [Related]
14. Indazole derivatives and their therapeutic applications: a patent review (2013-2017).
Denya I; Malan SF; Joubert J
Expert Opin Ther Pat; 2018 Jun; 28(6):441-453. PubMed ID: 29718740
[TBL] [Abstract][Full Text] [Related]
15. Steroidal pyrazolines as a promising scaffold in drug discovery.
Bansal R; Singh R
Future Med Chem; 2020 May; 12(10):949-959. PubMed ID: 32319322
[TBL] [Abstract][Full Text] [Related]
16. Current scenario of pyrazole hybrids with in vivo therapeutic potential against cancers.
Xu Z; Zhuang Y; Chen Q
Eur J Med Chem; 2023 Sep; 257():115495. PubMed ID: 37209450
[TBL] [Abstract][Full Text] [Related]
17. Quantitative and Qualitative Analysis of the Anti-Proliferative Potential of the Pyrazole Scaffold in the Design of Anticancer Agents.
Nitulescu GM
Molecules; 2022 May; 27(10):. PubMed ID: 35630776
[TBL] [Abstract][Full Text] [Related]
18. Synthetic approaches, structure activity relationship and biological applications for pharmacologically attractive pyrazole/pyrazoline-thiazolidine-based hybrids.
Havrylyuk D; Roman O; Lesyk R
Eur J Med Chem; 2016 May; 113():145-66. PubMed ID: 26922234
[TBL] [Abstract][Full Text] [Related]
19. Recent Developments in the Antimicrobial Potential of Some Nitrogenous Heterocycles and their SAR Studies: A Review.
Nehra B; Kumar M; Singh S; Chawla V; A Chawla P; Grover P
Curr Med Chem; 2024 May; ():. PubMed ID: 38797910
[TBL] [Abstract][Full Text] [Related]
20. Recent progress on pyrazole scaffold-based antimycobacterial agents.
Keri RS; Chand K; Ramakrishnappa T; Nagaraja BM
Arch Pharm (Weinheim); 2015 May; 348(5):299-314. PubMed ID: 25820461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
